Development of a Transplantation Risk Index in Patients With Mechanical Circulatory Support A Decision Support Tool

被引:24
作者
Johnston, Lily E. [1 ,2 ]
Grimm, Joshua C. [3 ]
Magruder, J. Trent [3 ]
Shah, Ashish S. [4 ]
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] Univ Virginia, Div Thorac & Cardiovasc Surg, Charlottesville, VA USA
[3] Johns Hopkins Univ Hosp, Div Cardiac Surg, Baltimore, MD 21287 USA
[4] Vanderbilt Univ, Med Ctr, Dept Cardiac Surg, Nashville, TN USA
关键词
cardiac transplantation; mechanical circulatory support; risk modeling; VENTRICULAR ASSIST DEVICE; CARDIAC TRANSPLANTATION; HEART-TRANSPLANTATION; DESTINATION THERAPY; DONOR ALLOCATION; SURVIVAL; IMPACT; MORTALITY; REGISTRY; NETWORK;
D O I
10.1016/j.jchf.2015.11.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to develop a risk index specific to patients on mechanical circulatory support that accurately predicts 1-year mortality after orthotopic heart transplantation using the United Network for Organ Sharing database. BACKGROUND Few clinical tools are available to aid in the decision between continuing long-term device support and performing transplantation in patients bridging with mechanical circulatory support. METHODS Using a prospectively collected, open cohort, 6,036 patients receiving mechanical circulatory support who underwent orthotopic heart transplantation between 2000 and 2013 were evaluated and randomly separated into derivation (80%) and validation (20%) groups. Multivariate logistic regression models were constructed using variables that improved the explanatory power of the model, which was determined using multiple methods. Points for a simple additive risk index were apportioned on the basis of relative effect on odds of 1-year mortality. RESULTS A 75-point scoring system was created from 9 recipient and 4 donor variables. The average score in the validation cohort was 14.4 +/- 7.7, and scores ranged from 0 to 57; these values were similar to those in the derivation cohort. Each 1-point increase predicted an 8.3% increase in the odds of 1-year mortality (odds ratio: 1.08; 95% confidence interval: 1.06 to 1.11). Low (0 to 10), intermediate (11 to 20), and high (>20) risk score cohorts were created, with predicted average 1-year mortalities of 8.6%, 12.8%, and 31%, respectively, in the validation cohort. CONCLUSIONS The investigators present a novel, internally cross-validated risk index that accurately predicts mortality in bridge-to-transplantation patients. (C) 2016 by the American College of Cardiology Foundation.
引用
收藏
页码:277 / 286
页数:10
相关论文
共 17 条
[1]  
Birks EJ, 2011, TEX HEART I J, V38, P552
[2]   Transplant Registrants With Implanted Left Ventricular Assist Devices Have Insufficient Risk to Justify Elective Organ Procurement and Transplantation Network Status 1A Time [J].
Dardas, Todd ;
Mokadam, Nahush A. ;
Pagani, Francis ;
Aaronson, Keith ;
Levy, Wayne C. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (01) :36-43
[3]   MODELING AND VARIABLE SELECTION IN EPIDEMIOLOGIC ANALYSIS [J].
GREENLAND, S .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1989, 79 (03) :340-349
[4]   Impact of Ventricular Assist Device Complications on Posttransplant Survival: An Analysis of the United Network of Organ Sharing Database [J].
Healy, Aaron H. ;
Baird, Bradley C. ;
Drakos, Stavros G. ;
Stehlik, Josef ;
Selzman, Craig H. .
ANNALS OF THORACIC SURGERY, 2013, 95 (03) :870-875
[5]   Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: Impact of duration of left ventricular assist device support and other variables [J].
John, Ranjit ;
Pagani, Francis D. ;
Naka, Yoshifumi ;
Boyle, Andrew ;
Conte, John V. ;
Russell, Stuart D. ;
Klodell, Charles T. ;
Milano, Carmelo A. ;
Rogers, Joseph ;
Farrar, David J. ;
Frazier, O. Howard .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 140 (01) :174-181
[6]   Results of the Destination Therapy Post-Food and Drug Administration Approval Study With a Continuous Flow Left Ventricular Assist Device A Prospective Study Using the INTERMACS Registry (Interagency Registry for Mechanically Assisted Circulatory Support) [J].
Jorde, Ulrich P. ;
Kushwaha, Sudhir S. ;
Tatooles, Antone J. ;
Naka, Yoshifumi ;
Bhat, Geetha ;
Long, James W. ;
Horstmanshof, Douglas A. ;
Kormos, Robert L. ;
Teuteberg, Jeffrey J. ;
Slaughter, Mark S. ;
Birks, Emma J. ;
Farrar, David J. ;
Park, Soon J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (17) :1751-1757
[7]   Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients [J].
Kirklin, James K. ;
Naftel, David C. ;
Kormos, Robert L. ;
Stevenson, Lynne W. ;
Pagani, Francis D. ;
Miller, Marissa A. ;
Baldwin, J. Timothy ;
Young, James B. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (02) :141-156
[8]   Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation? [J].
Kirklin, James K. ;
Naftel, David C. ;
Pagani, Francis D. ;
Kormos, Robert L. ;
Stevenson, Lynne ;
Miller, Marissa ;
Young, James B. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (03) :584-603
[9]   Mechanical Circulatory Support and Heart Transplantation: Donor and Recipient Factors Influencing Graft Survival [J].
Maltais, Simon ;
Jaik, Nikhil P. ;
Feurer, Irene D. ;
Wigger, Mark A. ;
DiSalvo, Thomas G. ;
Schlendorf, Kelly H. ;
Ahmad, Rashid M. ;
Lenihan, Daniel J. ;
Stulak, John M. ;
Keebler, Mary E. .
ANNALS OF THORACIC SURGERY, 2013, 96 (04) :1252-1258
[10]  
Schulze PC, 2014, JACC-HEART FAIL, V2, P166